Literature DB >> 17308314

Appearance self-esteem in systemic sclerosis--subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables.

W G J M van Lankveld1, M C Vonk, H Teunissen, F H J van den Hoogen.   

Abstract

OBJECTIVES: To determine the importance of skin deformity in systemic sclerosis (SSc) relative to other disease stressors and to find psychological correlates of appearance self-esteem (ASE) after controlling for disease status.
METHODS: Disease-related stressors, symptoms, physical and psychological functioning, social support, coping styles, cognitions and ASE were assessed in 123 patients with SSc. A rheumatologist determined disease duration, SSc subtype, presence of organ involvement and skin-thickness scores. Stepwise hierarchical regression analysis of disease-related cognitions on ASE was performed after controlling for selected variables.
RESULTS: Skin deformities proved a core stressor of the disease, only preceded by fatigue. Physician-assessed disease status, including modified Rodnan skin score, was unrelated to ASE. Sex, self-reported functioning and symptoms were related to ASE and used as control variables. Both acceptance and anxiety correlated strongly with ASE. The stepwise regression procedure only identified the disease-related cognition acceptance.
CONCLUSIONS: In SSc, ASE proved unrelated to the extent of skin thickness. Psychological interventions aimed at boosting ASE should primarily target the psychological factors acceptance and anxiety.

Entities:  

Mesh:

Year:  2007        PMID: 17308314     DOI: 10.1093/rheumatology/kem008

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  31 in total

1.  The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat's technique and kinesitherapy: a randomized controlled trial.

Authors:  S Maddali-Bongi; G Landi; F Galluccio; A Del Rosso; I Miniati; M L Conforti; R Casale; M Matucci-Cerinic
Journal:  Rheumatol Int       Date:  2010-03-18       Impact factor: 2.631

2.  Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.

Authors:  Sarah D Mills; Rina S Fox; Erin L Merz; Philip J Clements; Suzanne Kafaja; Vanessa L Malcarne; Daniel E Furst; Dinesh Khanna
Journal:  J Rheumatol       Date:  2015-06-01       Impact factor: 4.666

3.  New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Authors:  Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

4.  High sensitivity optical measurement of skin gloss.

Authors:  Anna Ezerskaia; Arno Ras; Pascal Bloemen; Silvania F Pereira; H Paul Urbach; Babu Varghese
Journal:  Biomed Opt Express       Date:  2017-08-07       Impact factor: 3.732

Review 5.  Fatigue in rheumatic diseases.

Authors:  Sevinç Can Sandıkçı; Zeynep Özbalkan
Journal:  Eur J Rheumatol       Date:  2015-09-01

Review 6.  Negative affect in systemic sclerosis.

Authors:  Leticia Leon; Lydia Abasolo; Marta Redondo; Miguel Angel Perez-Nieto; Luis Rodriguez-Rodriguez; Maria Isabel Casado; Rafael Curbelo; Juan Angel Jover
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

7.  The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Authors:  Brooke Levis; Linda Kwakkenbos; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Clin Rheumatol       Date:  2016-12-10       Impact factor: 2.980

8.  Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life.

Authors:  Mustafa Akif Sariyildiz; Ibrahim Batmaz; Mahmut Budulgan; Mehtap Bozkurt; Levent Yazmalar; Ahmet Inanir; Tahsin Celepkolu; Remzi Çevik
Journal:  Rheumatol Int       Date:  2013-01-31       Impact factor: 2.631

Review 9.  A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples.

Authors:  B D Thombs; M Bassel; L McGuire; M T Smith; M Hudson; J A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2008-08-13       Impact factor: 7.580

10.  Fatigue: an overlooked determinant of physical function in scleroderma.

Authors:  S B Sandusky; L McGuire; M T Smith; F M Wigley; J A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2008-12-23       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.